These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3012965

  • 1. Establishment and characterization of an adriamycin-resistant subline of human small cell lung cancer cells.
    Miyamoto H.
    Acta Med Okayama; 1986 Apr; 40(2):65-73. PubMed ID: 3012965
    [Abstract] [Full Text] [Related]

  • 2. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I, Ohnoshi T, Hiraki S, Miyamoto H.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [Abstract] [Full Text] [Related]

  • 3. In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells.
    Miyamoto H.
    Acta Med Okayama; 1986 Apr; 40(2):75-81. PubMed ID: 3012966
    [Abstract] [Full Text] [Related]

  • 4. [Cytotoxic effect of topoisomerase II inhibitors against adriamycin- and etoposide-resistant small cell lung cancer sublines].
    Takigawa N, Ohnoshi T, Ueoka H, Yonei T, Kiura K, Tabata M, Kodani T, Kamei H, Segawa Y, Shibayama T.
    Gan To Kagaku Ryoho; 1993 May; 20(7):929-35. PubMed ID: 8387762
    [Abstract] [Full Text] [Related]

  • 5. Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.
    Kiura K, Ohnoshi T, Tabata M, Shibayama T, Kimura I.
    Acta Med Okayama; 1993 Jun; 47(3):191-7. PubMed ID: 8104372
    [Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
    Ikubo S, Takigawa N, Ueoka H, Kiura K, Tabata M, Shibayama T, Chikamori M, Aoe K, Matsushita A, Harada M.
    Anticancer Res; 1999 Jun; 19(5B):3985-8. PubMed ID: 10628341
    [Abstract] [Full Text] [Related]

  • 7. Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line.
    Takigawa N, Ohnoshi T, Ueoka H, Kiura K, Kimura I.
    Acta Med Okayama; 1992 Jun; 46(3):203-12. PubMed ID: 1354408
    [Abstract] [Full Text] [Related]

  • 8. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K, Ohnoshi T, Ueoka H, Takigawa N, Tabata M, Segawa Y, Shibayama T, Kimura I.
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [Abstract] [Full Text] [Related]

  • 9. A close association of adriamycin resistance with expression of cell surface antigens in adriamycin-resistant cell lines of herpes simplex virus type 2-transformed Syrian hamster cells.
    Kimura S, Okazaki K.
    Jpn J Cancer Res; 1985 Dec; 76(12):1179-85. PubMed ID: 3005209
    [Abstract] [Full Text] [Related]

  • 10. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
    Nokihara H, Yano S, Nishioka Y, Hanibuchi M, Higasida T, Tsuruo T, Sone S.
    Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
    [Abstract] [Full Text] [Related]

  • 11. Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line.
    Matsuo K, Kiura K, Ueoka H, Tabata M, Shibayama T, Matsumura T, Takigawa N, Hiraki S, Harada M.
    Acta Med Okayama; 1997 Jun; 51(3):121-7. PubMed ID: 9227790
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
    Takigawa N, Ohnoshi T, Ueoka H, Kiura K, Moritaka T, Tabata M, Segawa Y, Shibayama T, Gemba K, Matsumura T.
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):473-7. PubMed ID: 8383949
    [Abstract] [Full Text] [Related]

  • 15. Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.
    Naoe Y, Inami M, Takagaki S, Matsumoto S, Kawamura I, Nishigaki F, Tsujimoto S, Manda T, Shimomura K.
    Jpn J Cancer Res; 1998 Oct; 89(10):1047-54. PubMed ID: 9849584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 18. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
    Coley HM, Twentyman PR, Workman P.
    Biochem Pharmacol; 1989 Dec 15; 38(24):4467-75. PubMed ID: 2604747
    [Abstract] [Full Text] [Related]

  • 19. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.
    Fukumoto H, Nishio K, Ohta S, Hanai N, Fukuoka K, Ohe Y, Sugihara K, Kodama T, Saijo N.
    Int J Cancer; 1999 Aug 27; 82(5):759-64. PubMed ID: 10417777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.